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A 2-year-old boy with grade IV neuroblastoma presented with acute neurogenic bladder and
hyposthenia after 2 weeks of treatment with anti-ganglioside-GD2 antibody (GD2-Ab). Spinal
MRI findings are shown in the figure. On nerve conduction studies, there was sensorimotor
demyelinating polyneuropathy with secondary axonal features, without conduction block. CSF
Figure Spine MRI findings
Contrast-enhanced sagittal (A), coro-
nal (B), and axial (C) T1-weighted
images show enhancing lumbosa-
cral nerves (arrows, A, B) with almost
selective involvement of the cauda
equina dorsal roots (arrows, C).
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examination revealed albuminocytologic dissociation. Senso-
rimotor polyneuropathy is a potential neurotoxic effect of
anti-GD2-Ab.1 Spinal nerves contrast enhancement might be
related to the binding of anti-GD2-Ab to spinal nerves myelin,
determining active myelin breakdown. Anti-GD2-Ab toxicity
should be included in the differential diagnosis of spinal nerve
root contrast enhancement in children.2
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